mPharma

We are invested in mPharma through Novastar Ventures Africa Fund II, which is managed by Novastar Ventures.

We do not hold direct relationships with the companies that investment funds invest in. Instead, we hold relationships directly with the fund. When investing through investment funds, CDC takes an active role as a limited partner to the fund, working with the fund manager to ensure best practices, including in environment, social and governance matters, and investment management oversight.

mPharma offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications. The company aims to improve pharmaceutical cag

For further information on the fund, the fund manager, and the expected impact of the fund’s investment, click here.

Key facts

Status:
Active
Investment type

We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).
:
Intermediated investment
Fund:
Novastar Ventures Africa Fund II
Fund Manager:
Novastar Ventures
Start date

For direct investments, this is the date CDC committed capital to the business or project.

For funds, this is the date that CDC committed capital to the fund.

For underlying fund investments, this is the date that the fund invested capital into the business.e
:
May 2019
Domicile

This is the investee company’s place of incorporation; or a fund’s jurisdiction.
:
USA
Back to investments

How we invest

Find out more

Portfolio data

Find out more